\n
\nReceive an email when new articles are posted on \n<\/p>\n\nPlease provide your email address to receive an email when new articles are posted on
.<\/p>\n<\/div>\n<\/div>\n” data-action=subscribe> We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.<\/strong> <\/p>\nBack to Healio<\/button><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\nKey takeaways:<\/h2>\n\nFlu vaccine effectiveness ranged from 34% to 60% among children and adolescents from 2021 to 2024.<\/li>\n The effectiveness from 2022 to 2024 was comparable to pre-pandemic effectiveness.<\/li>\n<\/ul>\nInfluenza vaccination continues to protect children from influenza-related outpatient visits and hospitalizations, according to post-pandemic data published in Pediatrics.<\/i> <\/p>\n
\u201cWe have had really severe recent seasons for flu, particularly in children,\u201d Samantha M. Olson, MPH, <\/b>an epidemiologist in the CDC\u2019s influenza division, told Healio in an interview. \u201cThis study really adds to the growing body of evidence showing how protective flu vaccines can be for infants, children and adolescents, and this includes even the most severe outcomes.\u201d<\/p>\n\n\nData derived from Olson SM, et al. Pediatrics<\/i>. 2026;doi:10.1542\/peds.2025-073973. Olson and colleagues used data from seven pediatric medical centers that are part of the New Vaccine Surveillance Network for the 2021-2022, 2022-2023 and 2023-2024 influenza seasons to estimate vaccine effectiveness against influenza-related outpatient and hospital visits among children. The study included 19,917 children aged 6 months through 17 years who received outpatient care or were hospitalized for acute respiratory illness across three seasons. <\/p>\n
Researchers reported an overall vaccine effectiveness of 55%, with varying effectiveness each season, ranging from 34% to 60%.<\/p>\n
Following a season with very low influenza circulation, the 2021-2022 season had the lowest vaccine effectiveness (34%). Out of 3,247 children included in the study during this season, 339 tested positive for influenza. According to researchers, 37% of children with influenza were vaccinated, compared with 51% of children without influenza.<\/p>\n
\u201cSince we didn\u2019t have any data at a global level to look at which flu strains were circulating, it was really hard to predict which would be in the 2021-2022 season,\u201d Olson said. \u201cSo, we ended up with a season where we had a flu virus that was different from the vaccine.\u201d<\/p>\n
During the 2022-2023 season, 832 children tested positive for influenza. According to the study, only 22% of children who had influenza were vaccinated, compared with 44% of the 5,926 children without influenza. Similarly, out of the 1,660 children who tested positive during the 2023-2024 season, 24% were vaccinated, compared with 45% of the 8,225 without. Vaccine effectiveness rose to 51% in 2022-2023 and to 60% in 2023-2024.<\/p>\n
Overall, vaccine effectiveness was 57% against outpatient visits and 50% against hospitalizations among children and adolescents during the study period, according to researchers.<\/p>\n
\u201c[Among] all of the different ages, outcomes and types of influenza, we see really good protection,\u201d Olson said. \u201cThese findings are very similar to what we saw in seasons prior to these years.\u201d<\/p>\n
For more information:<\/h2>\n Samantha M. Olson, MPH,<\/b> <\/b>can be reached at pediatrics@healio.com. <\/p>\n\n
\n
\n
<\/p>\n
Ask a clinical question<\/strong> and tap into Healio AI’s knowledge<\/strong> base.<\/p>\n\nPubMed, enrolling\/recruiting trials, guidelines<\/li>\n Clinical Guidance, Healio CME, FDA news<\/li>\n Healio’s exclusive daily news coverage of clinical data<\/li>\n<\/ul>\nLearn more<\/button>\n<\/div>\n<\/div>\n